Xiaozhou Zou

498 total citations
19 papers, 372 citations indexed

About

Xiaozhou Zou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiaozhou Zou has authored 19 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Xiaozhou Zou's work include Pulmonary Hypertension Research and Treatments (7 papers), MicroRNA in disease regulation (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Xiaozhou Zou is often cited by papers focused on Pulmonary Hypertension Research and Treatments (7 papers), MicroRNA in disease regulation (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Xiaozhou Zou collaborates with scholars based in China and Canada. Xiaozhou Zou's co-authors include Chang-Ping Hu, Ting Liu, Zhicheng Gong, Zheng Zhang, Ting Liu, Weifang Zhang, Ping Huang, Xiao-Yue Ge, Ning Huang and Xiao Hu and has published in prestigious journals such as Journal of Ethnopharmacology, Life Sciences and Molecular Cancer.

In The Last Decade

Xiaozhou Zou

18 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaozhou Zou China 11 200 124 122 51 51 19 372
Xiaofeng Zou China 12 304 1.5× 153 1.2× 77 0.6× 55 1.1× 44 0.9× 42 447
Qiaoyun Long China 12 264 1.3× 107 0.9× 59 0.5× 57 1.1× 58 1.1× 20 479
Xingxing Chen China 12 164 0.8× 106 0.9× 157 1.3× 79 1.5× 41 0.8× 28 383
Chunting Tan China 12 195 1.0× 57 0.5× 160 1.3× 31 0.6× 38 0.7× 22 470
Si-An Xie China 10 184 0.9× 69 0.6× 73 0.6× 30 0.6× 66 1.3× 20 337
Xiaodi Yan China 12 290 1.4× 136 1.1× 57 0.5× 48 0.9× 51 1.0× 30 430
Fengping Zheng China 7 259 1.3× 221 1.8× 229 1.9× 55 1.1× 59 1.2× 20 511
Tania Tsatralis Australia 10 191 1.0× 79 0.6× 34 0.3× 40 0.8× 37 0.7× 11 335
Feng Cao China 13 200 1.0× 151 1.2× 75 0.6× 62 1.2× 45 0.9× 33 385
Bowen Shi China 11 150 0.8× 60 0.5× 104 0.9× 62 1.2× 24 0.5× 48 384

Countries citing papers authored by Xiaozhou Zou

Since Specialization
Citations

This map shows the geographic impact of Xiaozhou Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhou Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhou Zou more than expected).

Fields of papers citing papers by Xiaozhou Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhou Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhou Zou. The network helps show where Xiaozhou Zou may publish in the future.

Co-authorship network of co-authors of Xiaozhou Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhou Zou. A scholar is included among the top collaborators of Xiaozhou Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhou Zou. Xiaozhou Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Yiwen, Xiaoxia Li, Zhiyong Sun, et al.. (2025). Effect of Sceptridium ternatum extract (STE) on radiation-induced pulmonary fibrosis by inhibiting cell adhesion factor CEACAM1. Journal of Ethnopharmacology. 345. 119550–119550. 1 indexed citations
2.
3.
Zou, Xiaozhou, et al.. (2024). SOX17 Prevents Endothelial–Mesenchymal Transition of Pulmonary Arterial Endothelial Cells in Pulmonary Hypertension through Mediating TGF-β/Smad2/3 Signaling. American Journal of Respiratory Cell and Molecular Biology. 72(4). 364–379. 3 indexed citations
4.
Liu, Ting, et al.. (2024). Emerging connectivity of programmed cell death pathways and pulmonary vascular remodelling during pulmonary hypertension. Journal of Cellular and Molecular Medicine. 28(16). e70003–e70003. 5 indexed citations
5.
6.
Zou, Xiaozhou, et al.. (2024). Optimization of fermentation conditions for the production of γ-aminobutyric acid by Lactobacillus hilgardii GZ2 from traditional Chinese fermented beverage system. Bioprocess and Biosystems Engineering. 47(6). 957–969. 4 indexed citations
7.
Zou, Xiaozhou, Ting Liu, Zhongjie Huang, et al.. (2023). SOX17 is a Critical Factor in Maintaining Endothelial Function in Pulmonary Hypertension by an Exosome‐Mediated Autocrine Manner. Advanced Science. 10(14). e2206139–e2206139. 23 indexed citations
8.
Zhang, Yiwen, Lu Lu, Feifeng Song, et al.. (2023). Research progress on non-protein-targeted drugs for cancer therapy. Journal of Experimental & Clinical Cancer Research. 42(1). 62–62. 14 indexed citations
9.
Pan, Zongfu, Xiao Hu, Tiefeng Jin, et al.. (2022). CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Molecular Cancer. 21(1). 190–190. 68 indexed citations
10.
Zou, Xiaozhou, Yiwen Zhang, Zongfu Pan, et al.. (2022). Gentiopicroside alleviates cardiac inflammation and fibrosis in T2DM rats through targeting Smad3 phosphorylation. Phytomedicine. 106. 154389–154389. 22 indexed citations
11.
Song, Feifeng, et al.. (2022). Efficacy of Qingfei oral liquid for idiopathic pulmonary fibrosis in rats and related network pharmacology study. Journal of Zhejiang University (Medical Sciences). 51(1). 53–61. 1 indexed citations
12.
Lou, Jiang, Wei Yan, Qingyu Li, et al.. (2020). LncRNA MEG8 plays an oncogenic role in hepatocellular carcinoma progression through miR-367-3p/14-3-3ζ/TGFβR1 axis. Neoplasma. 68(2). 273–282. 19 indexed citations
13.
Liu, Ting, Chen-Huan Yu, Xiuli Yang, et al.. (2020). LncRNA TUG1 alleviates cardiac hypertrophy by targeting miR‐34a/DKK1/Wnt‐β‐catenin signalling. Journal of Cellular and Molecular Medicine. 24(6). 3678–3691. 19 indexed citations
14.
Liu, Ting, Xiaozhou Zou, Ning Huang, et al.. (2019). Down-regulation of miR-204 attenuates endothelial-mesenchymal transition by enhancing autophagy in hypoxia-induced pulmonary hypertension. European Journal of Pharmacology. 863. 172673–172673. 32 indexed citations
15.
Liu, Ting, Xiaozhou Zou, Ning Huang, et al.. (2019). miR-27a promotes endothelial-mesenchymal transition in hypoxia-induced pulmonary arterial hypertension by suppressing BMP signaling. Life Sciences. 227. 64–73. 32 indexed citations
16.
Zou, Xiaozhou, et al.. (2018). Inhibitory effect and mechanism of Adina rubella flavonoids on platelet aggregation and thrombosis. Zhongguo linchuang yaolixue yu zhiliaoxue. 23(6). 640. 1 indexed citations
17.
Zou, Xiaozhou, Zhicheng Gong, Ting Liu, et al.. (2017). Involvement of epithelial-mesenchymal transition afforded by activation of LOX-1/ TGF-β1/KLF6 signaling pathway in diabetic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 44. 70–77. 31 indexed citations
18.
Zou, Xiaozhou, Ting Liu, Zhicheng Gong, Chang-Ping Hu, & Zheng Zhang. (2016). MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. European Journal of Pharmacology. 796. 190–206. 60 indexed citations
19.
Li, Xianwei, Chang-Ping Hu, Weihua Wu, et al.. (2012). Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: Role of ERK1/2 and p27. European Journal of Pharmacology. 679(1-3). 117–126. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofeng Zou Breakdown of academic impact, for papers by Qiaoyun Long Breakdown of academic impact, for papers by Xingxing Chen Breakdown of academic impact, for papers by Chunting Tan Breakdown of academic impact, for papers by Si-An Xie Breakdown of academic impact, for papers by Xiaodi Yan Breakdown of academic impact, for papers by Fengping Zheng Breakdown of academic impact, for papers by Tania Tsatralis Breakdown of academic impact, for papers by Feng Cao Breakdown of academic impact, for papers by Bowen Shi
Rankless by CCL
2026